Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Steven Webber

High Impact

Executive Vice Chancellor and Dean

Also affiliated: Boston Children's Hospital (2003); Cleveland Clinic (2001); Joint United Nations Programme on HIV/AIDS (2009); University of Miami (2012); University of Pittsburgh (1995–2012); Vanderbilt University (2014); Hospital for Sick Children (2012); Southampton General Hospital (1998); Mount Sinai Medical Center (2001); Children's Hospital of Pittsburgh (2000–2012); University of Pittsburgh Medical Center (2001–2009); NIHR Surgical Reconstruction and Microbiology Research Centre (2018); SickKids Foundation (2012); The Stables (2009); Carnegie Mellon University (2006); University of Pennsylvania (2002); Temple University (2001); Vanderbilt University Medical Center (2020)

Faculty Researcher

21 h-index 54 pubs 3,462 cited

  • Humans
  • Child
  • Heart Transplantation
  • Female
  • Male
  • Child, Preschool
  • Adolescent
  • Infant
  • Graft Rejection
  • Infant, Newborn
  • Retrospective Studies
  • Adult
  • Organ Transplantation
  • Treatment Outcome
  • Postoperative Complications

Biography and Research Information

OverviewAI-generated summary

Steven Webber's research focuses on genetic factors influencing pediatric cardiomyopathies and outcomes following organ transplantation in children. He has investigated the genetic architecture of pediatric cardiomyopathy, identifying genetic causes for the condition. His work also addresses post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation in children, contributing to consensus guidelines for Epstein-Barr virus (EBV) load monitoring and prevention strategies.

Webber has also published on advancements and future directions in pediatric heart transplantation. His research explores mechanisms of chronic rejection, such as dysregulated Treg repair responses after heart transplantation, and contributes to understanding antibody-mediated rejection. Additionally, he has investigated methods for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy using cardiac imaging and biomarkers.

With an h-index of 21 and over 3,455 citations across 54 publications, Webber is recognized as a highly cited researcher. He leads a research group and remains recently active in his field, with his most recent publication in 2025.

Metrics

  • h-index: 21
  • Publications: 54
  • Citations: 3,462

Selected Publications

  • Six-Month Outcomes in Children With COVID-19 or Multisystem Inflammatory Syndrome in Children (2026)
  • Abstract 4346346: Biomarkers in Patients with Newly Diagnosed Dilated Cardiomyopathy: A Study from the Pediatric Cardiomyopathy Registry (2025)
  • Abstract 4346181: The Impact of Genotype on Phenotypic Severity and Survival in Pediatric Dilated Cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry (2025)
  • Dysregulated Treg repair responses lead to chronic rejection after heart transplantation (2024)
    Journal of Clinical Investigation 19 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

74 Collaborators 49 Institutions 2 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics